Table 1 Attributes and levels for the choice questions
From: Physicians’ preferences for bone metastases treatments in France, Germany and the United Kingdom
Attribute | Levels |
|---|---|
Time until first SRE | 28 months |
18 months | |
10 months | |
Time until a 2-point increase in pain on the BPI | 10 months |
6 months | |
3 months | |
Risk of ONJ each year | None |
1 out of 100 (1%) | |
5 out of 100 (5%) | |
Risk of 0.5 mg/dL increase in baseline creatinine level each year (risk of renal impairment) | None |
4 out of 100 (4%) | |
10 out of 100 (10%) | |
Mode of administration | Daily oral tablet Injection every 4 weeks |
15-min infusion every 4 weeks | |
120-min infusion every 4 weeks |